A decrease in pain, particularly in the morning, is a good sign
The GLP-1 drugs in the study which included semaglutide (sold as Wegovy and Ozempic), liraglutide, dulaglutide, and exenatide have skyrocketed in popularity in recent years for weight loss and blood sugar control
Efficacy and safety of once weekly semaglutide 24 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): A double-blind, multicentre, randomised controlled trial
Biomarkers and metabolic measures also showed much greater improvement in the semaglutide group vs
Reducing dryness and fine lines
Morton points to retatrutide, a weekly injection from Eli Lilly currently in clinical development for obesity and type 2 diabetes, as an example